Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 26 of 144 pages ‹ First < 24 25 26 27 28 > Last ›
HSL14275
Pfizer uses viral marketing to press quit-smoking message
mad.co.uk 2008 Sep 5
http://www.mad.co.uk/Logon/ArticleLogon.aspx?uiArticleID=12d20e57-de7c-4108-8c7b-63c4f5e1aad9&uiNavigationItemID=&uiPageID=8453a00f-9d1a-404a-beda-339905b6b8b4&PipelinedPage=/Main/News/Articlex/12d20e57de7c41088c7b63c4f5e1aad9/Pfizer-uses-viral-marketing-to-press-quit-smoking-message.html&PipelinedQueryString=uiArticleID%3d12d20e57-de7c-4108-8c7b-63c4f5e1aad9%26uiNavigationItemID%3dd8f9fd23-813a-47b2-9696-31d9ca23a265%26
HSL14276
Prescription Drug Advertising Subject of New FDA Web Site for Consumers
PharmaLive 2008 Sep 5
http://pharmalive.com/news/index.cfm?articleID=569075&categoryid=9&newsletter=1
HSL14316
Eisenberg T, Wells MT.
Statins and Adverse Cardiovascular Events in Moderate-Risk Females: A Statistical and Legal Analysis with Implications for FDA Preemption Claims
Journal of Empirical Legal Studies 2008 Sep 5; 5:(3):507 - 550
http://www3.interscience.wiley.com/journal/121400492/abstract
HSL14241
Dey S.
Post offices may soon sell medicines
The Economic Times 2008 Sep 4
http://economictimes.indiatimes.com/News_by_Industry/Post_offices_may_soon_sell_medicines_/articleshow/3442043.cms
HSL14242
Being unique is a disorder
The Age (Melbourne), originally from The Independent 2008 Sep 4
http://www.theage.com.au/news/health/being-unique-is-a-disorder/2008/09/03/1220121331199.html?page=fullpage#contentSwap2
HSL14557
Bates AK.
Implementing a pre-launch named patient programme: Evidence of increased market share
Journal of Medical Marketing 2008 Sep 4; (8):319–324
http://www.palgrave-journals.com/jmm/journal/v8/n4/abs/jmm200825a.html
HSL14228
Rothman DJ, Chimonas S.
New Developments in Managing Physician-Industry Relationships
JAMA 2008 Sep 3; 300:(9):1067
http://jama.ama-assn.org/cgi/content/extract/300/9/1067
HSL14230
Relman AS.
Industry Support of Medical Education
JAMA 2008 Sep 3; 300:(9):1071-1073
http://jama.ama-assn.org/cgi/content/extract/300/9/1071
HSL14239
Bruderlin-Nelson C.
Pfizer's Lipitor ad returns, sans celebrity
FiercePharma 2008 Sep 3
http://www.fiercepharma.com/story/pfizers-creative-advertising-under-fire/2008-09-03?utm_medium=nl&utm_source=internal&cmp-id=EMC-NL-FP&dest=FP
HSL14240
Lamay C.
Idaho presses case against best-selling medication
IdahoStatesman.com 2008 Sep 3
http://www.idahostatesman.com/business/story/491303.html
HSL14246
Edwards J.
Pfizer Courting More Controversy with Viagra ‘Advergaming’
BNET 2008 Sep 3
http://industry.bnet.com/pharma/1000196/pfizer-courting-more-controversy-with-viagra-advergaming/
HSL14247
Lakin M.
Study Casts Doubt on Value of DTC Ads
Advertising Age 2008 Sep 3
http://adage.com/article?article_id=130732
HSL14301
Maisonneuve H, Touboul C, Bonnelye G, Bertrand D.
[French hospital doctors attend many educational programmes but have organisational and financial difficulties for their continuing medical education.]
Presse Med 2008 Sep 3; epub ahead of print
http://www.em-consulte.com/article/181774
HSL14340
Ross K.
Crackdown on unproven cancer treatments focuses on internet marketers.
J Natl Cancer Inst. 2008 Sep 3; 100:(17):1200-2
http://jnci.oxfordjournals.org/cgi/content/full/100/17/1200
HSL14363
Lee AC, Radford J.
The ranibizumab saga of drug profiteering.
BMJ 2008 Sep 3; 337:a1532:
http://www.bmj.com/cgi/content/full/337/sep03_3/a1532
HSL14216
Berenson A.
For Widely Used Drug, Question of Usefulness Lingers
The New York Times 2008 Sep 2
http://www.nytimes.com/2008/09/02/business/02vytorin.html?_r=1&oref=slogin
HSL14226
Piwowar HA, Becich BJ, Bilofsky H, Crowley RS.
Towards a Data Sharing Culture: Recommendations for Leadership from Academic Health Centers
PLoS Med. 2008 Sep 2; 5:(9):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050183
HSL14227
Holmes B.
Drugs ads may be a waste of money
NewScientist 2008 Sep 2
http://www.newscientist.com/article/dn14643-drugs-ads-may-be-a-waste-of-money.html
HSL14229
Angell M.
Industry-Sponsored Clinical Research: A Broken System
JAMA 2008 Sep 2; 300:(9):1069
http://jama.ama-assn.org/cgi/content/extract/300/9/1069
HSL14232
Drugs: Direct-to-consumer ads may be a waste of cash
Yahoo Finance 2008 Sep 2
http://health.yahoo.com/news/afp/healthdrugsuscanadamarketing_080902104507.html
HSL14233
Law MR, Majumdar SR, Soumerai SB, .
Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study
BMJ 2008 Sep 2; 337:
http://www.bmj.com/cgi/content/abstract/337/sep02_1/a1055
HSL14234
Mintzes B.
Direct to consumer advertising of prescription drugs
BMJ 2008 Sep 2; 337:
http://www.bmj.com/cgi/content/extract/337/sep02_1/a985
HSL14235
Drug Ads: Big Waste Of Money?
The Washington Post 2008 Sep 2
http://www.washingtonpost.com/wp-dyn/content/article/2008/08/29/AR2008082902646.html
HSL14237
Editorial Board of Psychiatric Times to Disclose COIs
Integrity in Science Watch 2008 Sep 2
http://www.cspinet.org/integrity/watch/200809021.html#3
HSL14245
Quelch J.
How to Create a Blockbuster
BusinessWeek 2008 Sep 2
http://www.businessweek.com/managing/content/sep2008/ca2008092_971760.htm?chan=top+news_top+news+index+-+temp_managing
HSL14225
Taylor L.
Criminal probe into Roche Xenical sales continues
PharmaTimes 2008 Sep 1
http://www.pharmatimes.com/WorldNews/article.aspx?id=14244&src=EWorldNews
HSL14236
Mansell P.
Antipsychotics more than triple stroke risk in dementia
PharmaTimes 2008 Sep 1
http://www.pharmatimes.com/WorldNews/article.aspx?id=14246&src=EWorldNews
HSL14278
Value of Direct-to-Consumer Drug Advertising Oversold, Study Finds
PharmaLive 2008 Sep 1
http://pharmalive.com/news/index.cfm?articleID=567494&categoryid=43
HSL14513
Prounis C.
Bolder is Better
Pharmaceutical Executive 2008 Sep 1
http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=548884
HSL14183
Sufrin CB, Ross JS.
Pharmaceutical Industry Marketing: Understanding Its Impact on Women's Health.
Obstet Gynecol Surv. 2008 Sep; 63:(9):585-596
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=LyTZ1lSQ1gJFG1yNlLlsl88x1V2QgzyQJlytCZHQgRlms25JJ5hp!2126095447!181195629!8091!-1?doi=10.1097/OGX.0b013e31817f1585
HSL14203
Editorial .
Credibility crisis in pediatric psychiatry
Nature Neuroscience 2008 Sep; 11:(9):983
http://www.nature.com/neuro/journal/v11/n9/index.html
HSL14218
Brand R.
Marketing drugs: debating the real cost: Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts
State Legis. 2008 Sep; 34:(8):26-9
http://www.ncbi.nlm.nih.gov/pubmed/18754159
HSL14254
Jones K.
In whose interest? Relationships between health consumer groups and the pharmaceutical industry in the UK.
Sociol Health Illn. 2008 Sep; 30:(6):929-43
http://www3.interscience.wiley.com/journal/121390263/abstract?CRETRY=1&SRETRY=0
HSL14255
Abraham J.
Sociology of pharmaceuticals development and regulation: a realist empirical research programme.
Sociol Health Illn. 2008 Sep; 30:(6):869-85
http://www3.interscience.wiley.com/journal/121390260/abstract
HSL14257
Conrad P, Leiter V.
From Lydia Pinkham to Queen Levitra: direct-to-consumer advertising and medicalisation.
Sociol Health Illn 2008 Sep; 30:(6):825-38
http://www3.interscience.wiley.com/journal/121390265/abstract
HSL14277
Miller DP, Mansfield RJ, Woods JB, Wofford JL, Moran WP.
The Impact of Drug Samples on Prescribing to the Uninsured.
South Med J. 2008 Sep; 101:(9):888-893
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=LG2bNprpTlvScKfScMcN6FpBv9ngnpwJTZjdgn8bbx0SmqzWRdvv!609209752!181195628!8091!-1?doi=10.1097/SMJ.0b013e3181814d52
HSL14288
Downey LV.
What is the impact of free drug samples on patients?
South Med J 2008 Sep; 101:(9):879-80
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=LJJf0LG6MHLkQQ0lgGPFzcbDPpbPkLsFGcw1w0x5sglGqCnY2Pwf!612563345!181195628!8091!-1?doi=10.1097/SMJ.0b013e318180bd18
HSL14339
Smith PB, Benjamin DK Jr, Murphy MD, Johann-Liang R, Iyasu S, Gould B, Califf RM, Li JS, Rodriguez W.
Safety monitoring of drugs receiving pediatric marketing exclusivity.
Pediatrics 2008 Sep; 122:(3):e628-33
http://pediatrics.aappublications.org/cgi/content/full/122/3/e628
HSL14357
Liesegang TJ.
Commercialism, Loss of Professionalism, and the Effect on Journals
Archives of Ophthalmology 2008 Sep; 126:(9):1292-1295.
http://archopht.ama-assn.org/cgi/content/extract/126/9/1292
HSL14359
Zhang Y.
Cost-saving effects of olanzapine as long-term treatment for bipolar disorder.
The Journal of Mental Health Policy and Economics 2008 Sep; 11:(3):135-46
http://www.icmpe.net/fulltext.php?volume=11&page=135&year=2008&num=3&name=Zhang%20Y
HSL14365
Coleman DL.
Establishing policies for the relationship between industry and clinicians: lessons learned from two academic health centers.
Acad Med. 2008 Sep; 83:(9):882-7
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=LyqVctvHhyVBJFd79Xy4x1LJr7GFmWpDTW1gcLQnn2KT87sSyGLk!-1052912739!181195629!8091!-1?an=00001888-200809000-00022
HSL14366
Liesegang TJ, Albert DM, Schachat AP.
How to ensure our readers' trust: the proper attribution of authors and contributors.
Am J Ophthalmol. 2008 Sep; 146:(3):337-40
http://linkinghub.elsevier.com/retrieve/pii/S0002-9394(08)00459-5
HSL14388
Nesi T
Poison Pills: The Untold Story of the Vioxx Drug Scandal
: Macmillan 2008 Sep
http://us.macmillan.com/poisonpills
HSL14471
Steiner TJ.
Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry--report and recommendations of the Ethics Subcommittee of the International Headache Society.
Cephalalgia 2008 Sep; 28:Suppl 3:1-25
http://www3.interscience.wiley.com/cgi-bin/fulltext/120776174/PDFSTART
HSL14517
Miao-Sheng C, Yu-Ti S.
Pricing of prescription drugs and its impact on physicians' choice behavior.
Health Care Manag Sci 2008 Sep; 11:(3):288-95
http://www.ncbi.nlm.nih.gov/pubmed/18826006
HSL14575
Strehl E.
[Surveillance--more than a marketing instrument?].
Med Monatsschr Pharm. 2008 Sep; 31:(9):346-50
http://www.ncbi.nlm.nih.gov/pubmed/18831466
HSL14604
Tomaszewski C.
Blinding in peer review.
J Med Toxicol. 2008 Sep; 4:(3):147-8
https://strands02.strandspublishing.com/strands/jmt/login.htm;jsessionid=BED1D3FE4221D61A06D7AE13773AF507
HSL14638
Mastroianni FC, Noto AR.
Newsmaking on drugs: a qualitative study with journalism professionals.
J Psychoactive Drugs 2008 Sep; 40:(3):293-300
http://www.ncbi.nlm.nih.gov/pubmed/19004421
HSL14856
Peddecord KM, Jacobson IG, Engelberg M, Kwizera L, Macias V, Gustafson KW.
Can movie theater advertisements promote health behaviors? Evaluation of a flu vaccination pilot campaign.
J Health Commun. 2008 Sep; 13:(6):596-613
http://www.informaworld.com/smpp/content~db=all?content=10.1080/10810730802285149
HSL14857
Freeman B, Chapman S.
Gone viral? Heard the buzz? A guide for public health practitioners and researchers on how Web 2.0 can subvert advertising restrictions and spread health information.
J Epidemiol Community Health 2008 Sep; 62:(9):778-82
http://jech.bmj.com/cgi/content/full/62/9/778
HSL14858
Filippini G, Moja L, Liberati A, Gensini GF, Gusinu R, Conti AA.
When drug companies select what they want to publish patients are denied relevant therapeutic information.
Intern Emerg Med 2008 Sep; 3:(3):255-7
http://www.springerlink.com/content/h4h89873k570r710/
HSL16797
Charlton BG.
Zombie science: a sinister consequence of evaluating scientific theories purely on the basis of enlightened self-interest.
Med Hypotheses 2008 Sep; 71:(3):327-9
http://linkinghub.elsevier.com/retrieve/pii/S0306-9877(08)00234-X
HSL14214
Jenkins J.
Doc Q scrubs website: Advised to remove drug ads
The Toronto Sun 2008 Aug 31
http://www.torontosun.com/News/TorontoAndGTA/2008/08/31/6620431-sun.html
HSL14231
Park C.
Anti-psychotic drugs for kids get state look
Arkansas Democrat Gazette 2008 Aug 31
http://www.nwanews.com/adg/national/235834/
HSL14253
Gulhati CM.
Illegal Approval to Market Letrozole for Infertility in India
Monthly Index of Medical Specialities - India 2008 Aug 31;
HSL14207
Mundy A.
Making a Name for Drugs Without Using Their Names
The Wall Street Journal 2008 Aug 29
http://online.wsj.com/article/SB121996938848181717.html?mod=2_1566_topbox
HSL14208
Hill M.
GlaxoSmithKline drug ad sparks a debate
The Inquirer (Philadelphia) 2008 Aug 29
http://www.philly.com/philly/business/27649374.html
HSL14212
Several lawsuits target prescription drug Seroquel
Pittsburgh Post-Gazette 2008 Aug 28
http://www.post-gazette.com/pg/08241/907556-53.stm
HSL14256
Fox NJ, Ward KJ.
Pharma in the bedroom. . . and the kitchen. . . . The pharmaceuticalisation of daily life
Sociol Health Illn 2008 Aug 28; 30:(6):856 - 868
http://www3.interscience.wiley.com/journal/121390267/abstract
HSL14364
Dompé S.
Changes in the rules now governing Italy's drug industry.
Nature 2008 Aug 28; 454:(7208):1049
http://www.nature.com/doifinder/10.1038/4541049c
HSL14591
Williams SJ, Gabe J, Davis P.
The sociology of pharmaceuticals: progress and prospects
Sociology of Health & Illness 2008 Aug 28; 30:(6):813 - 824
http://www3.interscience.wiley.com/journal/121390261/abstract?CRETRY=1&SRETRY=0
HSL14194
Half GPs unaware of NPS
Pharmacy Daily (Australia) - registration required 2008 Aug 27
http://www.pharmacydaily.com.au
HSL14213
Attorney predicts next big corporate scandal will be off-label drug marketing
The Dallas Morning News 2008 Aug 27
http://www.dallasnews.com/sharedcontent/dws/bus/columnists/chall/stories/DN-Hall_27bus.ART.State.Edition1.4d79998.html
HSL14259
Lachenbruch PA, Wasserstein R.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):904
http://jama.ama-assn.org/cgi/content/full/300/8/904
HSL14260
Maisonneuve H.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):903
http://jama.ama-assn.org/cgi/content/full/300/8/903
HSL14261
Ong HT, Cheah JS.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):903-4
http://jama.ama-assn.org/cgi/content/full/300/8/903-a
HSL14262
Balon R.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):902
http://jama.ama-assn.org/cgi/content/full/300/8/902
HSL14263
Costa SD.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):902-3
http://jama.ama-assn.org/cgi/content/full/300/8/902-a
HSL14264
Patrono C.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):901
http://jama.ama-assn.org/cgi/content/full/300/8/901
HSL14265
Hawkey CJ.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):901
http://jama.ama-assn.org/cgi/content/full/300/8/901-a
HSL14266
Ferris S, Galasko D, Kirby L.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):901-2
http://jama.ama-assn.org/cgi/content/full/300/8/901-b
HSL14267
Johnson KR, Lassere MN.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):900
http://jama.ama-assn.org/cgi/content/full/300/8/900
HSL14268
FitzGerald GA.
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA 2008 Aug 27; 300:(8):900-1
http://jama.ama-assn.org/cgi/content/full/300/8/900-a
HSL14451
Hariz M.
[Medically dangerous advertising of Treo].
Lakartidningen. 2008 Aug 27-Sep; 105:(35):2349
http://www.ncbi.nlm.nih.gov/pubmed/18833634
HSL14452
Forslund L, Gerdén B.
[It's only afterwards the Medical Products Agency can scrutinize advertisements].
Lakartidningen. 2008 Aug 27-Sep; 105:(35):2348
http://www.ncbi.nlm.nih.gov/pubmed/18833633
HSL14195
Day M.
Is NICE looking for more influence in new drug pricing plan?
PharmaTimes 2008 Aug 26
http://www.pharmatimes.com/WorldNews/article.aspx?id=14203&src=EWorldNews
HSL14197
Harris G.
Stanford to Limit Drug Maker Financing
The New York Times 2008 Aug 26
http://www.nytimes.com/2008/08/26/business/26drug.html?_r=1&oref=slogin
HSL14270
Gould M.
End of the free lunch?
BMJ 2008 Aug 26; 337:a1399:
http://www.bmj.com/cgi/content/full/337/aug26_1/a1399
HSL14196
Silverman E.
Glaxo HIV Ads Use Scare Tactics?
Pharmalot 2008 Aug 25
http://www.pharmalot.com/2008/08/glaxo-hiv-ads-use-scare-tactics/
HSL14198
Edwards J.
What Lilly Learned From Steak n Shake: A Q&A on Cymbalta
BNET 2008 Aug 25
http://industry.bnet.com/pharma/1000185/what-lilly-learned-from-steak-n-shake-a-qa-on-cymbalta/
HSL14199
Manhattan Research Announces Top 10 Product Sites Visited by Physicians
Manhattan Research 2008 Aug 25
http://www.manhattanresearch.com/newsroom/Press_Releases/top-pharma-product-websites-2008.aspx
HSL14200
Duprey R.
Lipitor Marketing Raises Blood Pressure
The Motley Fool 2008 Aug 25
http://www.fool.com/investing/value/2008/08/25/lipitor-marketing-raises-blood-pressure.aspx
HSL14201
Merck Report Could Alter Clinical Trials, Marketing
Clinical Trials Today 2008 Aug 25
http://www.clinicaltrialstoday.com/2008/08/merck-report-co.html
HSL14206
Garza S.
Allegations halt drug recommendations
The Daily Texan 2008 Aug 25
http://www.dailytexanonline.com/home/index.cfm?event=displayArticlePrinterFriendly&uStory_id=5b0d61d4-e5c6-4bbd-808d-9a41a575e833
HSL14645
'Le facteur humain' : le marketing pharmaceutique prend les médecins par les tripes, dit Mansfield
Pharmacritique 2008 Aug 25
http://pharmacritique.20minutes-blogs.fr/archive/2008/08/25/le-facteur-humain-le-marketing-pharmaceutique-prend-les-med.html
HSL14204
Perrone M.
New FDA labels may protect drug makers
Delaware Online 2008 Aug 24
http://www.delawareonline.com/apps/pbcs.dll/article?AID=/20080824/BUSINESS/808240328/1003
HSL14180
Boseley S, Evans R.
Drug giants accused over doctors' perks
The Guardian 2008 Aug 23
http://www.guardian.co.uk/society/2008/aug/23/health.pharmaceuticals
HSL14191
Silverman E.
Proposed CME Changes Unnerve Some CME Firms
Pharmalot 2008 Aug 22
http://www.pharmalot.com/2008/08/proposed-cme-changes-unnerve-some-cme-firms/
HSL14193
Brody H
The ADVANTAGE Revelations: Seeding Caught in the Act
Hooked: Ethics, Medicine and Pharma 2008 Aug 22
http://brodyhooked.blogspot.com/2008/08/advantage-revelations-seeding-caught-in.html
HSL14205
Stein R.
FDA to Revise Rules For Cold Medications Meant for Children
The Washington Post 2008 Aug 22
http://www.washingtonpost.com/wp-dyn/content/article/2008/08/22/AR2008082202698.html
HSL14173
Kim JJ, Goldie SJ.
Health and Economic Implications of HPV Vaccination in the United States.
NEJM 2008 Aug 21; 359:(8):821-32
http://content.nejm.org/cgi/content/full/359/8/821
HSL14174
Staton T.
Is Gardasil worth the cost?
FiercePharma 2008 Aug 21
http://www.fiercepharma.com/story/gardasil-worth-cost/2008-08-21
HSL14175
Staton T.
GSK to report organization grants
FiercePharma 2008 Aug 21
http://www.fiercepharma.com/story/gsk-report-organization-grants/2008-08-21
HSL14177
Goldstein J.
GlaxoSmithKline to Disclose Grants to Hospitals, Patient Groups
The Wall Street Journal 2008 Aug 21
http://blogs.wsj.com/health/2008/08/21/glaxosmithkline-to-disclose-grants-to-hospitals-patient-groups/
HSL14178
Perrone M.
Drugmakers battle for right to track prescriptions
The Star Ledger 2008 Aug 21
http://www.nj.com/business/times/index.ssf?/base/business-4/121929154661390.xml&coll=5
HSL14192
Blum J.
Drugmakers Given Legal Shield By Rule, Lawyers Say
Bloomberg.com 2008 Aug 21
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aHcEVZn2wJhY
HSL14271
Lenzer J.
Truly independent research?
BMJ 2008 Aug 21; 337:a1332:
http://www.bmj.com/cgi/content/full/337/aug21_1/a1332
HSL14151
Perrone M.
States Fight To Prevent Big Pharma Data Mining
theday.com 2008 Aug 20
http://www.theday.com/re.aspx?re=a0144aea-2ba8-49a5-ae06-c17d8f6da7a3
HSL14152
Rosenthal E.
Drug Makers’ Push Leads to Cancer Vaccines’ Rise
The New York Times 2008 Aug 20
http://www.nytimes.com/2008/08/20/health/policy/20vaccine.html?_r=2&sq=merck&st=cse&scp=3&pagewanted=all&oref=slogin&oref=slogin
HSL14165
Podolsky SH, Greene JA.
A Historical Perspective of Pharmaceutical Promotion and Physician Education
JAMA 2008 Aug 20; 300:(7):831
http://jama.ama-assn.org/cgi/content/extract/300/7/831
Page 26 of 144 pages ‹ First < 24 25 26 27 28 > Last ›
